Page Mark, Ojugo Agatha, Imami Nesrina, Hardy Gareth, Gotch Frances, Almond Neil
Division of Retrovirology, National Institute for Biological Standards and Control, Potters Bar EN6 3QG, UK.
AIDS. 2007 Jan 30;21(3):375-7. doi: 10.1097/QAD.0b013e328012b873.
Antibody responses against human leukocyte antigen (HLA) classes I and II were detected in HIV-1 infected individuals who received a fixed inactivated HIV-1 (Remune) immunotherapy. The response was specific for HLA-B62 and HLA-DR4 concordant with the host cell line, HUT-78, used in vaccine production. These responses were not detected in HLA-B62 and HLA-DR4-positive individuals indicating that immunotherapy did not break tolerance to self-antigens.
在接受固定灭活HIV-1(Remune)免疫疗法的HIV-1感染个体中,检测到了针对人类白细胞抗原(HLA)I类和II类的抗体反应。该反应对与疫苗生产中使用的宿主细胞系HUT-78一致的HLA-B62和HLA-DR4具有特异性。在HLA-B62和HLA-DR4阳性个体中未检测到这些反应,这表明免疫疗法未打破对自身抗原的耐受性。